New partner for Withers & Rogers LLP supports ongoing expansion

European intellectual property firm Withers & Rogers has appointed Simon Bradbury as a partner to support the ongoing expansion of the firm’s pharmaceutical and cell and gene therapy groups. 

Having previously worked in-house at a global corporation, Bradbury is well-positioned to provide commercially focused advice to his clients. He holds an Intellectual Property Litigation Certificate and is a UPC Representative. Bradbury is also ranked in Band 1 by Chambers & Partners, listed as a Key Lawyer by the Legal500, listed as an IP Star by Managing IP, and ranked in IAM Strategy 300 for Legal, Biotech, Medical Devices, and Pharmaceuticals/Life Sciences.

Having studied Genetics at the University of Liverpool, Bradbury gained a master’s degree in oncology at the University of Nottingham. He has considerable expertise in cell and gene therapy, microbiome, medical devices, and next-generation diagnostics and is skilled in creating IP strategies for startups, spinouts, and SMEs.

Fiona McBride, Chair of Withers & Rogers, said: “Simon has significant experience in helping businesses in the life sciences and biotechnology sector to understand the importance of IP.  He has first-hand experience in helping innovative businesses leverage their IP assets to achieve their commercial potential by securing investment, agreeing on licensing deals, or securing a market listing.

“I am delighted to welcome Simon to the partnership to support the ongoing expansion of our successful pharmaceutical and cell and gene therapy groups.”

← Back to Movers & Shakers